The New England Journal of Medicine | Research & Review …
The New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research and review articles, and editorial opinion on a wide variety of topics of ...
New England Journal of Medicine
The New England Journal of Medicine publishes new medical research, review articles, and editorial opinion on a wide variety of topics.
Current Issue | New England Journal of Medicine
Explore the current issue of The New England Journal of Medicine (Vol. 391 No. 24).
Recently Published - The New England Journal of Medicine
Dec 11, 2024 · The BALANCE Investigators, for the Canadian Critical Care Trials Group, the Association of Medical Microbiology and Infectious Disease Canada Clinical Research Network, the Australian and New ...
Nonsurgical Management of Chronic Venous Insufficiency
Dec 18, 2024 · Chronic venous insufficiency arises from a complex interplay of genetic predisposition; environmental factors, such as jobs that require prolonged standing or carrying heavy loads; and age-related ...
Original Article - The New England Journal of Medicine
Dec 19, 2024 · In two replicate trials, depemokimab, an ultra-long-acting anti–interleukin-5 biologic therapy, reduced exacerbations in patients who had severe asthma with an eosinophilic phenotype.
Beta-Blockers after Myocardial Infarction and Preserved Ejection ...
Apr 7, 2024 · From September 2017 through May 2023, a total of 5020 patients were enrolled (95.4% of whom were from Sweden). The median follow-up was 3.5 years (interquartile range, 2.2 to 4.7).
Durvalumab in Small-Cell Lung Cancer | NEJM
Dec 18, 2024 · To the Editor: Results of the phase 3 ADRIATIC trial (Oct. 10 issue)1 marked a breakthrough in the treatment of limited-stage small-cell lung cancer, but some questions remain unanswered.
Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients …
Apr 3, 2024 · Nirmatrelvir in combination with ritonavir is an antiviral treatment for mild-to-moderate coronavirus disease 2019 (Covid-19). The efficacy of this treatment in patients who are at standard risk ...
Bedaquiline Monotherapy for Multibacillary Leprosy
Dec 11, 2024 · Standard treatment for multibacillary leprosy is multidrug therapy consisting of dapsone, rifampicin, and clofazimine, with a recommended treatment duration of 12 months. 4 Challenges include ...